Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
Main Authors: | Annika Klumpp, MD, Felix Luessi, MD, Sinah Engel, MD, Beate Weidenthaler-Barth, MD, Detlef Becker, MD, Stephan Grabbe, MD, Hadrian Schepler, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512622003538 |
Similar Items
-
Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia
by: Tyler A. Hooton, MD, et al.
Published: (2021-03-01) -
Necrotizing Escherichia coli skin and soft tissue infection with malakoplakia-like features mimicking pyoderma gangrenosum
by: Alexander M. Hammond, BS, et al.
Published: (2021-06-01) -
Spesolimab use in treatment of pyoderma gangrenosum
by: Sophie H. Guénin, MSc, et al.
Published: (2023-04-01) -
A case of extracutaneous pyoderma gangrenosum in a patient with persistent cutaneous and systemic symptoms: Implications for differential diagnosis and treatment
by: Gabriella Santa Lucia, MSCR, et al.
Published: (2021-09-01) -
Resolution of therapy-resistant pyoderma gangrenosum with upadacitinib
by: Lisa Van Eycken, MD, et al.
Published: (2023-07-01)